Navigation Links
Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
Date:3/3/2009

Studies Support Potential for Alzheimer's Disease and Other Neurodegenerative Diseases

NEW YORK, March 3 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease ("AD"), announced today that the chemical structure of OXIGON(TM) (indole-3-propionic acid) has been independently shown to form copper complexes. This discovery provides important insight into how the drug neutralizes the neurotoxicity of Alzheimer's beta-amyloid toxin, previously reported by several investigators. Also, it provides further support that OXIGON(TM) has broad potential for use in the treatment of other neurodegenerative conditions, such as Parkinson's disease, where metal binding is believed to induce the pathological aggregation of proteins. The discovery regarding the metal binding properties of OXIGON(TM) was reported by Professor Liang Hong and colleagues from Guangxi Normal University, Guilin, China, in February 2008 in an online publication, CJI.

Intellect is developing OXIGON(TM) as a drug candidate for AD. The drug, which has disease-modifying potential by preventing metal-dependent aggregation, neurotoxicity and deposition of beta amyloid, has been tested in human Phase I trials for safety and tolerability at various doses and different durations in a total of 90 elderly, healthy volunteers. The development of OXIGON(TM) as a drug candidate for AD has been supported in part by the National Institute of Aging, the BIRD Foundation and The Institute for the Study of Aging. The Company is seeking additional investments to support initiation of Phase II clinical trials for OXIGON(TM) in Alzheimer's patients.

Dr. Daniel Chain, Intellect's Chairman and CEO commented: "We were very interested to learn that OXIGON(TM) has metal binding properties." Dr. Chain added: "These data fit perf
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions
2. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
3. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
4. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
5. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
9. TissueGene Announces Regulatory Allowance to Initiate Phase IIa Study of TG-C in South Korea for Osteoarthritis of the Knee
10. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
11. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Apr. 17, 2015 Research and Markets ... of the "Medical Device Outsourcing - Global ... This report analyzes the worldwide markets ... the following Device Categories: Class I, Class II, ... in the report Include - Radiology, Orthopedic, Neurology, ...
(Date:4/17/2015)... , April 17, 2015 ASSESS ... mutation   is a viable alternative to tumour biopsy   ... in all patients with advanced NSCLC   AstraZeneca ... of plasma circulating tumour DNA (ctDNA) testing for epidermal growth ... advanced non-small cell lung cancer (NSCLC) in clinical practice. [ ...
(Date:4/17/2015)... 17, 2015 Research and Markets ( ... "Medical Oxygen Systems - Global Strategic Business Report" ... the worldwide markets for Medical Oxygen Systems in US$ ... Systems, Oxygen Cylinders & Regulators, and Oxygen Conserving Devices. ... Canada , Japan ...
Breaking Medicine Technology:Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 2Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2
... PHILADELPHIA, Nov. 7, 2011 The Children,s Hospital of ... Grand Challenges Explorations, an initiative created by the Bill ... test unorthodox ideas that address persistent health and development ... of Rheumatology at Children,s Hospital and Professor of Pediatrics ...
... efforts on behalf of the public and private healthcare industry ... today, according to a new book , "Health Industry ... J. Hicks and Christina Mazzola Nicols of Ketchum , ... The book, released this fall from Jones & Bartlett ...
Cached Medicine Technology:The Children's Hospital of Philadelphia Receives Grand Challenges Explorations Funding 2The Children's Hospital of Philadelphia Receives Grand Challenges Explorations Funding 3New Book Highlights Opportunities for Healthcare Industry Communications 2New Book Highlights Opportunities for Healthcare Industry Communications 3New Book Highlights Opportunities for Healthcare Industry Communications 4New Book Highlights Opportunities for Healthcare Industry Communications 5
(Date:4/17/2015)... From the day Dr. Todd Phillips founded The Last ... empowered young people to create meaningful change in their world. ... and the Gospel to all of Liberia by 2020 , ... 27, students, faculty and staff raised $21,000 through the TEN ... the Good News of Jesus. , During the campaign, ...
(Date:4/17/2015)... Enthusiasts of gourmet cuisine and beverages will be coming ... event will be held in the heart of downtown Grand ... Grand Rapids, MI 49503) and will feature wine personalities and ... encouraged to savor the food and beverage pairings while enjoying ... will feature seven chefs, including:, Chef ...
(Date:4/17/2015)... April 17, 2015 Testosterone treatment ... class of prescription medications increases the likelihood that ... or other life-threatening cardiovascular event continue to mount ... Court, Northern District of Illinois. According to an ... Panel on Multidistrict Litigation (JPML) on April 15th, ...
(Date:4/17/2015)... The American College of Traditional Chinese Medicine (ACTCM) is a hosting ... The event will be held from 11 a.m. to 4 p.m. ... San Francisco, CA. , The agenda for the day is as ... (room F), 11:10 a.m. – Introduction and welcome by admissions, ... current students, faculty and staff, 1 p.m. – Observe clinic theater ...
(Date:4/17/2015)... Carolina (PRWEB) April 17, 2015 With ... Dental Care has spent the last four years ... care, performing procedures ranging from general cleanings to dental ... a grand opening at their new office in North ... same services as their Concord office, including denture fittings, ...
Breaking Medicine News(10 mins):Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 3Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 4Health News:American College of Traditional Chinese Medicine Hosts Open House 2
... ... III in Webinar Series on Opportunities for Improvement in Various Stages of the RN ... ... human capital research firm, will host a webinar titled “When Engagement Isn’t Enough: Retaining ...
... ... magazine, won an Excellence in Financial Journalism Award from the New York State Society of ... ... contributing editor of CFO magazine , won an Excellence in Financial Journalism Award from ...
... ... Circulation Heart Failure, a journal of the American ... ventilator efficiency is more accurate than the current listing criteria for ... from such intervention. The study conclusions reinforce the science behind the ...
... ... has announced a collaboration with SkillSoft Asia Pacific to provide SkillSoft’s ... collaborate with SkillSoft to provide SkillSoft’s content to our clients” said ... the provision of our technology enabled learning needs. Our clients have ...
... ... services and solutions, has introduced iCAN, a feature-rich, streamlined approach to automated telephony services. ... fees and extremely quick turnaround times to start up. , ... Buffalo, New York (Vocus) April 6, 2010 -- IVR ...
... , ... firm, has developed a library of search optimized patient education content for urgent care websites. ... center as a local treatment option. Using this content helps the urgent care clinics ... , ...
Cached Medicine News:Health News:Morehead Presents Webinar on ,“When Engagement Isn't Enough: Retaining RNs”, 2Health News:CFO magazine Wins Excellence in Financial Journalism Award 2Health News:Study Published by Circulation Heart Failure Reinforces Science Behind Shape-HF Cardiopulmonary Exercise Testing Device 2Health News:Study Published by Circulation Heart Failure Reinforces Science Behind Shape-HF Cardiopulmonary Exercise Testing Device 3Health News:Study Published by Circulation Heart Failure Reinforces Science Behind Shape-HF Cardiopulmonary Exercise Testing Device 4Health News:PeopleStreme Collaborates with SkillSoft for Learning Management Content 2Health News:IVR Technology Group Announces iCANsm Services 2Health News:WebForDoctors' Medical Content Pages Direct Patients to Urgent Care Centers as Alternatives to Emergency Rooms 2Health News:WebForDoctors' Medical Content Pages Direct Patients to Urgent Care Centers as Alternatives to Emergency Rooms 3
Liquichek™ Ethanol/Ammonia Control is a liquid product used to monitor ethanol and ammonia test procedures in the clinical laboratory....
Lyphochek Assayed Chemistry Control requires no special diluent and has good reconstituted stability for enzymes and CO2. It is assayed for most major instruments and methodologies....
Lyphochek Benzo/TCA Control Set B is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and antidepressant drugs....
Lyphochek Endocrine Control is a human based product designed to monitor plasma catecholamine testing procedures by HPLC. The analytes are spiked at critical concentrations to cover the dynamic range...
Medicine Products: